Recent Updates — XRAY
DENTSPLY SIRONA Inc. reported second quarter 2026 financial results with net sales of $898 million, a 4.1% year-over-year decline. The company posted GAAP diluted earnings per share of $0.18 and adjusted EPS of $0.52. Operating cash flow improved to $99 million from $48 million in the prior year period, driven by approximately $44 million in tariff refunds. Free cash flow reached $55 million compared to $16 million previously. The company repurchased 1.3 million shares for approximately $12 million during the quarter and ended with $239 million in cash. Management reiterated its full-year 2026 outlook, targeting net sales between $3.5 billion and $3.6 billion and adjusted EPS of $1.40 to $1.50. DENTSPLY SIRONA Inc. is the world's largest diversified manufacturer of professional dental products and technologies.
DENTSPLY SIRONA Inc. reported financial results for its second fiscal quarter ended June 30, 2026. The company posted net sales of $898 million, a 4.1% decline from the prior year period. GAAP diluted earnings per share were $0.18, compared to a loss of $0.22 in Q2 2025. Adjusted EBITDA was $190 million with an adjusted EPS of $0.52. Operating cash flow improved to $99 million, driven by approximately $44 million in tariff refunds and working capital management. The company repurchased 1.3 million shares for $12 million during the quarter. Management reiterated its full-year 2026 outlook for net sales of $3.5 billion to $3.6 billion and adjusted EPS of $1.40 to $1.50. DENTSPLY SIRONA Inc. is a global manufacturer of professional dental products, technologies, and consumable medical devices.
DENTSPLY SIRONA Inc. appointed John C. Fortson as Executive Vice President & Chief Financial Officer, effective July 20, 2026. Mr. Fortson's compensation package includes a $780,000 annual base salary, an 85% target annual bonus, and a $500,000 sign-on cash payment due in February 2027. DENTSPLY SIRONA Inc. is a manufacturer of dental products and equipment.